Genentech Inc Drug Patent Portfolio

Genentech Inc's Family Patents

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Genprex Obtains Important International Patents for REQORSA Treatment - The Globe and Mail

25 Feb, 2026

Indian pharmaceutical company plans to offer Wegovy alternative at competitive prices, potentially up to a 60% discount.

18 Feb, 2026

Roche CEO calls on Switzerland to increase funding for new medications following agreement in the US - Bilyonaryo

22 Dec, 2025

Recursion's New CEO Discusses Transforming AI-Developed Medications into Clinical Evidence

01 Dec, 2025